CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...